Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cbff64022f95c237c0bd3ec8656ca |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-30096 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-30016 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-10088 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-055 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4842 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-7275 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T7-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06V10-25 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0042 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T7-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T7-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T7-0012 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T7-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4064 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00 |
filingDate |
2021-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfb625b95746a5d9e924668f3d021119 |
publicationDate |
2021-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2021222529-A1 |
titleOfInvention |
3d image analysis platform for neurological conditions |
abstract |
Disclosed herein are systems and methods of analyzing 3D structure of a portion of the CNS. An analytics module may be used to calculate one or more metrics the describe changes in the 3D structure of a CNS structure over time. The one or more metrics may be used to identify patterns of structural change prior to progressive symptom development. Healthcare providers may use the one or more metrics and or patterns of structural change to diagnose neurological conditions, track the progress of neurological conditions in the patient, and determine the patient's risk of progressive disease development. The 3D structure analytics techniques described herein may also be used to develop treatments and create a care delivery that is individualized for each patient. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023164562-A1 |
priorityDate |
2020-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |